← Evidence map

ReviewFrontiers in immunology2023

Bispecific antibodies targeting CTLA-4: game-changer troopers in cancer immunotherapy.

Pooya Farhangnia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

28 papers cite it

2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 37441075